|
|
Volumn 96 Suppl, Issue , 2009, Pages
|
|
Technical considerations for KRAS testing in colorectal cancer. The biologist's point of view;Aspect technique de la détermination du statut KRAS dans le cancer colorectal et mise en place en France. Point de vue du biologiste.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MONOCLONAL ANTIBODY;
PANITUMUMAB;
COLORECTAL TUMOR;
DRUG ANTAGONISM;
FRANCE;
GENETIC SCREENING;
GENETICS;
HUMAN;
METHODOLOGY;
MUTATION;
NUCLEOTIDE SEQUENCE;
ONCOGENE RAS;
PATHOLOGY;
QUALITY CONTROL;
REVIEW;
STANDARD;
ANTIBODIES, MONOCLONAL;
COLORECTAL NEOPLASMS;
DNA MUTATIONAL ANALYSIS;
FRANCE;
GENES, RAS;
GENETIC TESTING;
HUMANS;
MUTATION;
QUALITY CONTROL;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
MLCS;
MLOWN;
|
|
EID: 75549091511
PISSN: None
EISSN: 17696917
Source Type: Journal
DOI: 10.1684/bdc.2009.0996 Document Type: Review |
|
Times cited : (8)
|
|
References (20)
|
